The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials-Reference-Cited by-同舟云学术

The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials

Published:2014-06-05 Issue:30 Volume:35 Page:2001-2009
ISSN:1522-9645
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Anker Stefan D.,Agewall Stefan,Borggrefe Martin,Calvert Melanie,Jaime Caro J.,Cowie Martin R.,Ford Ian,Paty Jean A.,Riley Jillian P.,Swedberg Karl,Tavazzi Luigi,Wiklund Ingela,Kirchhof Paulus

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/35/30/2001/17354469/ehu205.pdf

Reference51 articles.

1. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims;US Department of Health and Human Services Food and Drug Administration,2009

2. Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: systematic review;Rahimi;BMJ,2010

3. A review of patient-reported outcome labels in the United States: 2006 to 2010;Gnanasakthy;Value Health,2012

4. Beyond survival: Recommendations from INTERMACS for assessing function and quality of life with mechanical circulatory support;Grady;J Heart Lung Transplant,2012

5. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes;Wilson;JAMA,1995

Cited by 286 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Item generation for a new patient-reported outcome measure: The non-traumatic anterior knee pain (AKP)-YOUTH scale;Musculoskeletal Science and Practice;2024-10

2. Effects of Glucagon-like Peptide-1 Receptor Agonists on Cardiac Function, Exercise Capacity and Quality of Life;Cardiac Failure Review;2024-09-11

3. Using patient-reported outcomes in clinical studies for cardiovascular diseases of Traditional Chinese medicine worldwide: a cross-sectional study;2024-08-17

4. Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial;Circulation: Heart Failure;2024-08

5. Efficacy of a Transition Program in Adolescents and Young Adults With Congenital Heart Disease: The TRANSITION-CHD Randomized Controlled Trial;Journal of Adolescent Health;2024-08